NewsBenzingaVivos Therapeutics、2026年第4四半期から年間360万ドルの削減を目指す再編およびコスト削減計画を発表 Vivos Therapeutics、2026年第4四半期から年間360万ドルの削減を目指す再編およびコスト削減計画を発表 Benzinga 2026.09.29 12:48 (GMT+0) Open on Benzinga Other news Wall Street Says the Muse AI Catalyst for Twilio Stock Is More Hype Than Substance Trump Signs Executive Order Launching America.gov to Unify Access to Federal Services State Street's Quarterly Earnings Preview: What You Need to Know JP Morgan Maintains Overweight on Yum Brands, Lowers Price Target to $150 Blockworks Launches On-Chain Intelligence Product Intel, Integrating Messari Data and Multi-Agent Analysis JP Morgan Maintains Neutral on US Foods Holdings, Lowers Price Target to $98
Blockworks Launches On-Chain Intelligence Product Intel, Integrating Messari Data and Multi-Agent Analysis
